{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:51:28Z","timestamp":1780361488828,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ygyno.2013.07.097","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T17:16:43Z","timestamp":1375118203000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: A SEER analysis"],"prefix":"10.1016","volume":"131","author":[{"given":"J. Alejandro","family":"Rauh-Hain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth J.","family":"Diver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Clemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Bradford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitfield B.","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"David M.","family":"Boruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela G.","family":"del Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.07.097_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1525-1438.2006.00760.x","article-title":"Current management of ovarian carcinosarcoma","volume":"17","author":"Mano","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.bjc.6600770","article-title":"Carcinosarcoma of the ovary","volume":"88","author":"Harris","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2004.02.016","article-title":"Survival of women diagnosed with malignant mixed mullerian tumors of the ovary (OMMMT)","volume":"93","author":"Barnholtz-Sloan","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a059312","article-title":"Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients","volume":"8","author":"Chang","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2011.02.023","article-title":"Carcinosarcoma of the ovary: a case\u2013control study","volume":"121","author":"Rauh-Hain","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0035","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1738::AID-CNCR21>3.0.CO;2-4","article-title":"Primary ovarian sarcoma\u2014analysis of prognostic variables and the role of surgical cytoreduction","volume":"82","author":"Sood","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0090-8258(89)80038-1","article-title":"Clinicopathological features of ovarian mixed mesodermal tumours and carcinosarcomas","volume":"32","author":"Terada","year":"1989","journal-title":"Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2007.01.037","article-title":"Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience","volume":"105","author":"Leiser","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.097_bb0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: a review of the literature","volume":"125","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2004.02.016","article-title":"Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT)","volume":"93","author":"Barnholtz-Sloan","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0060","author":"Surveillance, Epidemiology, and End Results (SEER) Program"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0065","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.20256","article-title":"Carcinosarcoma of the ovary: 19years of prospective data from a single center","volume":"10","author":"Brown","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.097_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2005.07.119","article-title":"Carcinosarcoma of the ovary\u2014a case series","volume":"100","author":"Rutledge","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.07.097_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2007.09.003","article-title":"Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum","volume":"108","author":"Cicin","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2004.01.007","article-title":"Gynecologic oncology group study. Cisplatin as initial chemotherapy in ovarian carcinosarcoma","volume":"93","author":"Thigpen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/gyno.1994.1081","article-title":"A gynecologic oncology group study. A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy","volume":"53","author":"Sutton","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/gyno.2000.5956","article-title":"Chemotherapy for malignant mixed mullerian tumors of the ovary","volume":"79","author":"Sit","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.097_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jamcollsurg.2006.08.005","article-title":"Racial disparities in late survival after rectal cancer surgery","volume":"203","author":"Morris","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jso.20932","article-title":"Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States","volume":"97","author":"Chan","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0110","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1546::AID-CNCR9>3.0.CO;2-M","article-title":"Cancer of the corpus uteri in white and black women in Michigan, 1985\u20131994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage","volume":"83","author":"Madison","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.07.097_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","article-title":"International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy In ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.07.097_bb0120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.1999.5501","article-title":"SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988\u20131994","volume":"74","author":"Cornelison","year":"1999","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813010172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T18:53:51Z","timestamp":1563562431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813010172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090825813010172"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.097","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: A SEER analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.07.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}